| Issuer | % of Class | Filed |
|---|---|---|
|
CVRx, Inc.
13D/A
Amendment 1
CVRX · 126638105
|
0.6% |
10/2/2026
Event 9/30/2026
|
|
WW International, Inc.
13G/A
Amendment 1
WW · 98262P200
|
7.5% |
8/26/2026
Event 8/26/2026
|
|
Neuronetics, Inc.
13D/A
Amendment 4
STIM · 64131A105
|
13.9% |
8/24/2026
Event 8/14/2026
|
|
CVRx, Inc.
13D
CVRX · 126638105
|
5.5% |
8/24/2026
Event 8/24/2026
|
|
Kazia Therapeutics Ltd
13G/A
Amendment 4
KZIA · 48669G105
|
19.6% |
8/19/2026
Event 8/5/2026
|
|
CVRx, Inc.
13G
CVRX · 126638105
|
5.5% |
8/14/2026
Event 8/7/2026
|
|
Neuronetics, Inc.
13D/A
Amendment 3
STIM · 64131A105
|
15.2% |
8/4/2026
Event 8/3/2026
|
|
Mobilicom Ltd
13G
MOB · Q6297L120
|
6.4% |
7/15/2026
Event 4/28/2026
|
|
SEACOR Marine Holdings Inc.
13D
SMHI · 78413P101
|
7.2% |
6/22/2026
Event 6/22/2026
|
|
Neuronetics, Inc.
13D/A
Amendment 2
STIM · 64131A105
|
15.2% |
5/27/2026
Event 5/19/2026
|
|
Kazia Therapeutics Ltd
13G/A
Amendment 3
KZIA · 48669G105
|
18.5% |
5/27/2026
Event 5/26/2026
|
|
Exagen Inc.
13G/A
Amendment 1
XGN · 30068X103
|
9.9% |
5/20/2026
Event 3/31/2026
|
|
SEACOR Marine Holdings Inc.
13G/A
Amendment 1
SMHI · 78413P101
|
6.9% |
5/20/2026
Event 3/31/2026
|
|
IO Biotech, Inc.
13G/A
Amendment 2
IOBTQ · 449778109
|
0% |
5/20/2026
Event 3/31/2026
|
|
CalciMedica, Inc.
13G/A
Amendment 1
CALC · 38942Q202
|
0% |
5/20/2026
Event 3/31/2026
|
|
WW International, Inc.
13G
WW · 98262P200
|
5.1% |
5/15/2026
Event 5/14/2026
|
|
Neuronetics, Inc.
13D/A
Amendment 1
STIM · 64131A105
|
14.1% |
4/8/2026
Event 4/6/2026
|
|
Neuronetics, Inc.
13D
STIM · 64131A105
|
14.1% |
3/31/2026
Event 3/31/2026
|
|
Kazia Therapeutics Ltd
13G/A
Amendment 2
KZIA · 48669G105
|
13.9% |
3/31/2026
Event 3/24/2026
|
|
Adagene Inc.
13G
ADAG · 005329107
|
5.1% |
3/18/2026
Event 3/16/2026
|
|
Neuronetics, Inc.
13G/A
Amendment 2
STIM · 64131A105
|
10.9% |
3/18/2026
Event 3/17/2026
|
|
Oncology Institute, Inc.
13G/A
Amendment 1
DFPH · 23343Q100
|
10.2% |
3/16/2026
Event 3/13/2026
|
|
Airsculpt Technologies, Inc.
13G/A
Amendment 2
AIRS · 009496100
|
10.8% |
3/4/2026
Event 3/2/2026
|
|
Kazia Therapeutics Ltd
13G/A
Amendment 1
KZIA · 48669G105
|
12.5% |
2/20/2026
Event 2/18/2026
|
|
OKYO Pharma Ltd
13G/A
Amendment 2
OKYO · G6724L116
|
9.5% |
2/13/2026
Event 12/31/2025
|
|
IO Biotech, Inc.
13G/A
Amendment 1
IOBTQ · 449778109
|
6.3% |
2/13/2026
Event 12/31/2025
|
|
Exagen Inc.
13G
XGN · 30068X103
|
5.4% |
2/4/2026
Event 1/30/2026
|
|
Neuronetics, Inc.
13G/A
Amendment 1
64131A1051
|
9.9% |
2/4/2026
Event 1/30/2026
|
|
Airsculpt Technologies, Inc.
13G/A
Amendment 1
AIRS · 009496100
|
9.9% |
2/4/2026
Event 1/30/2026
|
|
Traws Pharma, Inc.
13G
TRAW · 68232V884
|
6.8% |
1/16/2026
Event 1/14/2026
|
|
Airsculpt Technologies, Inc.
13G
AIRS · 009496100
|
5.1% |
1/16/2026
Event 1/14/2026
|
|
Oncology Institute, Inc.
13G
DFPH · 23343Q100
|
5.2% |
1/15/2026
Event 1/14/2026
|
|
SEACOR Marine Holdings Inc.
13G
SMHI · 78413P101
|
5.2% |
12/31/2025
Event 12/25/2025
|
|
Tiziana Life Sciences Ltd
13G/A
Amendment 2
TLSA · 88875G101
|
5.4% |
12/10/2025
Event 9/30/2025
|
|
CalciMedica, Inc.
13G
CALC · 38942Q202
|
7.9% |
12/1/2025
Event 11/24/2025
|
|
Neuronetics, Inc.
13G
64131A1051
|
6.4% |
11/24/2025
Event 11/17/2025
|
|
Tiziana Life Sciences Ltd
13G/A
Amendment 1
TLSA · 88875G101
|
6.1% |
11/14/2025
Event 9/30/2025
|
|
SEACOR Marine Holdings Inc.
13G/A
Amendment 1
SMHI · 78413P101
|
4.5% |
11/14/2025
Event 9/30/2025
|
|
OKYO Pharma Ltd
13G/A
Amendment 1
OKYO · G6724L116
|
7.8% |
11/14/2025
Event 9/30/2025
|
|
IO Biotech, Inc.
13G
IOBTQ · 449778109
|
5.3% |
11/5/2025
Event 10/30/2025
|
|
Lineage Cell Therapeutics, Inc.
13G
LCTX · 53566P109
|
5.0% |
9/26/2025
Event 9/22/2025
|
|
Femasys Inc.
13G/A
Amendment 1
FEMY · 31447E105
|
9.3% |
8/5/2025
Event 6/30/2025
|
|
Tiziana Life Sciences Ltd
13G
TLSA · 88875G101
|
5.0% |
6/12/2025
Event 6/11/2025
|
|
Kazia Therapeutics Ltd
13G
KZIA · 48669G105
|
9.9% |
6/12/2025
Event 6/11/2025
|
|
AEON Biopharma, Inc.
13G
AEON · 00791X209
|
9.9% |
5/30/2025
Event 5/27/2025
|
|
OKYO Pharma Ltd
13G
OKYO · G6724L116
|
6.8% |
5/27/2025
Event 5/23/2025
|
|
SEACOR Marine Holdings Inc.
13G
SMHI · 78413P101
|
5.2% |
4/21/2025
Event 4/4/2025
|
|
Femasys Inc.
13G
FEMY · 31447E105
|
6.2% |
2/26/2025
Event 2/19/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.